08.14.19
SP Scientific has signed a new partnership agreement with Lab-i-Dositechno Pharma Technologies enabling both companies to offer complete aseptic vial and syringe fill-finish lines for injectable, ophthalmic and oral products in liquid and powder form.
The global partnership brings together freeze drying and vial washing/sterilizing technologies from SP Scientific with the vial and syringe filling capabilities of Lab-i- Dositechno. The two companies will now provide development and manufacture of complete aseptic vial fill-finish lines offering a broad lyophilization range covering cycle development, stability, pilot and clinical batch production, through to full aseptic manufacturing and commercial production batches.
“The geographic synergies of SP Scientific and Lab-i-Dositechno working together will enable us to provide outstanding local support throughout North America and Europe, significantly broadening the reach of both partners,” said Oriol Casòliva, chief executive officer, Lab-i- Dositechno.
Brian Larkin, chief executive officer, SP Scientific, said, “In addition, for those who prefer to work with a single supplier for full lines, this new partnership enables us to provide and support these customers with top quality, highly productive aseptic fill-finish line solutions."
The global partnership brings together freeze drying and vial washing/sterilizing technologies from SP Scientific with the vial and syringe filling capabilities of Lab-i- Dositechno. The two companies will now provide development and manufacture of complete aseptic vial fill-finish lines offering a broad lyophilization range covering cycle development, stability, pilot and clinical batch production, through to full aseptic manufacturing and commercial production batches.
“The geographic synergies of SP Scientific and Lab-i-Dositechno working together will enable us to provide outstanding local support throughout North America and Europe, significantly broadening the reach of both partners,” said Oriol Casòliva, chief executive officer, Lab-i- Dositechno.
Brian Larkin, chief executive officer, SP Scientific, said, “In addition, for those who prefer to work with a single supplier for full lines, this new partnership enables us to provide and support these customers with top quality, highly productive aseptic fill-finish line solutions."